Fortis Malar Hospitals Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Chandrasekar Ramaswamy

Algemeen directeur

₹4.8m

Totale compensatie

Percentage CEO-salaris	86.9%
Dienstverband CEO	2.8yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	3.3yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Chandrasekar Ramaswamy's beloning veranderd ten opzichte van Fortis Malar Hospitals's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	₹482m
Mar 31 2024	₹5m	₹4m	₹453m
Dec 31 2023	n/a	n/a	-₹157m
Sep 30 2023	n/a	n/a	-₹129m
Jun 30 2023	n/a	n/a	-₹154m
Mar 31 2023	₹4m	₹4m	-₹155m
Dec 31 2022	n/a	n/a	-₹89m
Sep 30 2022	n/a	n/a	-₹105m
Jun 30 2022	n/a	n/a	-₹99m
Mar 31 2022	₹866k	₹861k	-₹83m

Compensatie versus markt: De totale vergoeding ($USD 56.54K ) Chandrasekar } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 42.81K ).

Compensatie versus inkomsten: De vergoeding van Chandrasekar is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Chandrasekar Ramaswamy (49 yo)

2.8yrs

Tenure

₹4,754,496

Compensatie

Mr. Chandrasekar Ramaswamy is Whole Time Director of Fortis Malar Hospitals Limited from January 11, 2022. He has experience across companies like Sanofi, GSK Pharmaceuticals, Medtronic and Dr. Lal Pathlab...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Chandrasekar Ramaswamy	Whole Time Director	2.8yrs	₹4.75m	geen gegevens
Daljit Singh	Chairman	9.9yrs	₹1.15m	geen gegevens
Ramesh Adige	Non-Executive Non-Independent Director	16.8yrs	₹1.20m	geen gegevens
Suvalaxmi Chakraborty	Additional Independent Director	less than a year	geen gegevens	geen gegevens
Shailaja Chandra	Non-Executive Independent Director	3.7yrs	₹800.00k	geen gegevens
Richa Debgupta	Non-Executive & Non-Independent Director	1.1yrs	geen gegevens	geen gegevens

3.3yrs

Gemiddelde duur

71yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 523696 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.3 jaar).

Fortis Malar Hospitals Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Fortis Malar Hospitals Limited Announces Change in Directorate

Fortis Malar Hospitals Limited Announces Resignation of Yogendra Kumar Kabra as Chief Financial Officer

Fortis Malar Hospitals Limited Announces Resignation of Yogendra Kumar Kabra as Chief Financial Officer

Fortis Malar Hospitals Limited Announces Resignation of Ms. Srishty as Company Secretary

Fortis Malar Hospitals Limited Announces Resignation of Ravi Rajagopal as Non-Executive Independent Director, Effective September 30, 2024

Fortis Malar Hospitals Limited, Annual General Meeting, Jul 31, 2024

Recent updates

Fortis Malar Hospitals Limited Announces Change in Directorate

Fortis Malar Hospitals Limited Announces Resignation of Yogendra Kumar Kabra as Chief Financial Officer

Fortis Malar Hospitals Limited Announces Resignation of Yogendra Kumar Kabra as Chief Financial Officer

Fortis Malar Hospitals Limited Announces Resignation of Ms. Srishty as Company Secretary

Fortis Malar Hospitals Limited Announces Resignation of Ravi Rajagopal as Non-Executive Independent Director, Effective September 30, 2024

Fortis Malar Hospitals Limited Declares Dividend for the Financial Year Ended March 31, 2024

Upcoming dividend of ₹2.50 per share

Fortis Malar Hospitals Limited to Report Q1, 2025 Results on Jul 22, 2024

Full year 2024 earnings released: EPS: ₹24.18 (vs ₹8.26 loss in FY 2023)

Fortis Malar Hospitals Limited to Report Q1, 2025 Results on Aug 14, 2024

Fortis Malar Hospitals Limited, Annual General Meeting, Jul 31, 2024

Investor sentiment improves as stock rises 21%

Full year 2024 earnings released: EPS: ₹24.18 (vs ₹8.26 loss in FY 2023)

Fortis Malar Hospitals Limited Proposes Final Dividend for the Year Ended March 31, 2024

Fortis Malar Hospitals Limited Announces Executive Appointments

New minor risk - Share price stability

Upcoming dividend of ₹40.00 per share

Fortis Malar Hospitals Limited Approves Declaration of Interim Dividend

Fortis Malar Hospitals Limited Approves Declaration of Interim Dividend

Fortis Malar Hospitals Limited Announces Resignation of Sandeep Singh as Company Secretary & Compliance Officer

Third quarter 2024 earnings released: ₹2.14 loss per share (vs ₹0.61 loss in 3Q 2023)

MGM Healthcare Private Limited completed the acquisition of Entire business operations of Fortis Malar Hospital, Chennai from Fortis Malar Hospitals Limited (BSE:523696).

New minor risk - Share price stability

National Consumer Disputes Redressal Commission, Delhi Dismisses Complaint Against Fortis Malar Hospital, Chennai and Its Doctors

National Consumer Disputes Redressal Commission, Delhi Dismisses Complaint Against Fortis Malar Hospital, Chennai and Its Doctors

Fortis Malar Hospitals Limited Approves the Appointment of Ms. Richa Singh Debgupta as an Additional Director (Non-Executive & Non-Independent) with Effect from October 10, 2023

Fortis Malar Hospitals Limited to Report Q2, 2023 Results on Aug 02, 2023

Fortis Malar Hospitals Limited Announces Resignation of Dr. Nithya Ramamurthy as Director

Full year 2023 earnings released: ₹8.26 loss per share (vs ₹4.41 loss in FY 2022)

Now 22% undervalued

Fortis Malar Hospitals Limited to Report Q3, 2024 Results on Feb 14, 2024

New minor risk - Share price stability

Fortis Malar Hospitals Limited to Report Fiscal Year 2023 Results on May 19, 2023

Fortis Malar Hospitals Limited to Report Q2, 2022 Results on Aug 02, 2022

Full year 2022 earnings released: ₹4.41 loss per share (vs ₹4.20 loss in FY 2021)

Fortis Malar Hospitals Limited to Report Q2, 2023 Results on Nov 14, 2022

Fortis Malar Hospitals Limited, Annual General Meeting, Jul 27, 2022

Fortis Malar Hospitals Limited, Annual General Meeting, Jul 27, 2022

Full year 2022 earnings released: ₹4.41 loss per share (vs ₹4.20 loss in FY 2021)

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: ₹2.01 loss per share (vs ₹1.56 loss in 2Q 2021)

Full year 2021 earnings released: ₹4.20 loss per share (vs ₹4.75 loss in FY 2020)

Full year 2021 earnings released: ₹4.20 loss per share (vs ₹4.75 loss in FY 2020)

Company Secretary & Compliance Officer has left the company

New 90-day high: ₹60.70

Fortis Malar Hospitals Limited Appoints Ms. Shailaja Chandra as an Independent Director

Third quarter 2021 earnings released: ₹0.50 loss per share (vs ₹1.32 loss in 3Q 2020)

Fortis Malar Hospitals Limited Appoints Shailaja Chandra as Independent Director of the Company

Fortis Malar Hospitals Limited Announces the Resignation of Mr. Murari Pejavar from the Position of the Independent Director

Fortis Malar Hospitals Limited to Report Q3, 2021 Results on Feb 01, 2021

New 90-day high: ₹53.70

New 90-day high: ₹50.45

Second quarter 2021 earnings released: ₹1.45 loss per share

New 90-day high: ₹50.25

First quarter earnings released

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd